Identifying and predicting longitudinal trajectories of care for people newly diagnosed with HIV in South Africa

Laura Platt, Ai Xu, Janet Giddy, Laura M Bogart, Andrew Boulle, Robert A Parker, Elena Losina, Ingrid V Bassett, Laura Platt, Ai Xu, Janet Giddy, Laura M Bogart, Andrew Boulle, Robert A Parker, Elena Losina, Ingrid V Bassett

Abstract

Background: Predicting long-term care trajectories at the time of HIV diagnosis may allow targeted interventions. Our objective was to uncover distinct CD4-based trajectories and determine baseline demographic, clinical, and contextual factors associated with trajectory membership.

Methods: We used data from the Sizanani trial (NCT01188941), in which adults were enrolled prior to HIV testing in Durban, South Africa from August 2010-January 2013. We ascertained CD4 counts from the National Health Laboratory Service over 5y follow-up. We used group-based statistical modeling to identify groups with similar CD4 count trajectories and Bayesian information criteria to determine distinct CD4 trajectories. We evaluated baseline factors that predict membership in specific trajectories using multinomial logistic regression. We examined calendar year of participant enrollment, age, gender, cohabitation, TB positivity, self-identified barriers to care, and ART initiation within 3 months of diagnosis.

Results: 688 participants had longitudinal data available. Group-based trajectory modeling identified four distinct trajectories: one with consistently low CD4 counts (21%), one with low CD4 counts that increased over time (22%), one with moderate CD4 counts that remained stable (41%), and one with high CD4 counts that increased over time (16%). Those with higher CD4 counts at diagnosis were younger, less likely to have TB, and less likely to identify barriers to care. Those in the least favorable trajectory (consistently low CD4 count) were least likely to start ART within 3 months.

Conclusions: One-fifth of people newly-diagnosed with HIV presented with low CD4 counts that failed to rise over time. Less than 40% were in a trajectory characterized by increasing CD4 counts. Patients in more favorable trajectories were younger, less likely to have TB, and less likely to report barriers to healthcare. Better understanding barriers to early care engagement and ART initiation will be necessary to improve long-term clinical outcomes.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Trajectories of square root CD4…
Fig 1. Trajectories of square root CD4 values for five years from study enrollment, as defined by group-statistical modeling. Group percentages reflect average posterior probabilities.

References

    1. Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, et al. Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies. PLOS Medicine. 2013. April 9;10(4):e1001418 10.1371/journal.pmed.1001418
    1. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Annals Of Internal Medicine. 2011. August 16;155(4):209–16. 10.7326/0003-4819-155-4-201108160-00358
    1. Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. Journal of the International AIDS Society. 2012;15(2):17383 10.7448/IAS.15.2.17383
    1. Bassett IV, Chetty S, Wang B, Mazibuko M, Giddy J, Lu Z, et al. Loss to Follow-Up and Mortality Among HIV-Infected People Co-Infected With TB at ART Initiation in Durban, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2012. January 1;59(1):25 10.1097/QAI.0b013e31823d3aba
    1. UNAIDS Country Profile, South Africa [Internet]. 2018 [cited 2019 Nov 25].
    1. McNairy ML, El-Sadr WM. The HIV care continuum: no partial credit given. AIDS. 2012. September;26(14):1735–8. 10.1097/QAD.0b013e328355d67b
    1. Rosen S, Fox MP. Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review. PLOS Medicine. 2011. July 19;8(7):e1001056 10.1371/journal.pmed.1001056
    1. Haber N, Pillay D, Porter K, Bärnighausen T. Constructing the cascade of HIV care: methods for measurement. Current Opinion in HIV and AIDS. 2016. January;11(1):102 10.1097/COH.0000000000000212
    1. Nagin DS, Odgers CL. Group-Based Trajectory Modeling in Clinical Research. 2010;33 10.1146/annurev.clinpsy.121208.131413
    1. Mody A, Eshun-Wilson I, Sikombe K, Schwartz SR, Beres LK, Simbeza S, et al. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis. PLOS Medicine. 2019. October 29;16(10):e1002959 10.1371/journal.pmed.1002959
    1. Powers KA, Samoff E, Weaver MA, Sampson LA, Miller WC, Leone PA, et al. Longitudinal HIV Care Trajectories in North Carolina. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2017. February 1;74:S88 10.1097/QAI.0000000000001234
    1. Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, et al. Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa. J Acquir Immune Defic Syndr. 2016. October 1;73(2):154–60. 10.1097/QAI.0000000000001025
    1. Bassett IV, Giddy J, Chaisson CE, Ross D, Bogart LM, Coleman SM, et al. A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial. BMC Infectious Diseases. 2013. August 26;13:390–390. 10.1186/1471-2334-13-390
    1. Hays RD, Sherbourne CD, Mazel RM. The rand 36-item health survey 1.0. Health Econ. 1993. October;2(3):217–27. 10.1002/hec.4730020305
    1. Sherbourne C, Stewart A. The MOS social Support Survey. Soc Sci Med. 1991;32(6):705–14. 10.1016/0277-9536(91)90150-b
    1. Craw JA, Gardner LI, Marks G, Rapp RC, Bosshart J, Duffus WA, et al. Brief Strengths-Based Case Management Promotes Entry Into HIV Medical Care: Results of the Antiretroviral Treatment Access Study-II. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2008. April;47(5):597–606. 10.1097/QAI.0b013e3181684c51
    1. Bassett IV, Xu A, Giddy J, Bogart LM, Boulle A, Millham L, et al. Assessing rates and contextual predictors of 5-year mortality among HIV-infected and HIV-uninfected individuals following HIV testing in Durban, South Africa. BMC Infect Dis. 2019. August 28;19(1):751 10.1186/s12879-019-4373-9
    1. Sherman G, Lilian R, Bhardwaj S, Candy S, Barron P. Laboratory information system data demonstrate successful implementation of the prevention of mother-to-child transmission programme in South Africa. S Afr Med J. 2014. March;104(3):235–8. 10.7196/samj.7598
    1. Cornell M, Lessells R, Fox MP, Fenner L, Myer L, Boulle A. Mortality Among Adults Transferred and Lost to Follow-up From Antiretroviral Therapy Programmes in South Africa: A Multicenter Cohort Study. J Acquir Immune Defic Syndr. 2014;67(2):9 10.1097/QAI.0000000000000269
    1. Wasserman L. Bayesian Model Selection and Model Averaging. Journal of Mathematical Psychology. 2000. March;44(1):92–107. 10.1006/jmps.1999.1278
    1. Drain PK, Losina E, Parker G, Giddy J, Ross D, Katz JN, et al. Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa. PLOS ONE. 2013. January 28;8(1):e55305 10.1371/journal.pone.0055305
    1. Fomundam HN, Tesfay AR, Mushipe SA, Mosina MB, Boshielo CT, Nyambi HT, et al. Prevalence and predictors of late presentation for HIV care in South Africa. South African Medical Journal. 2017. November 27;107(12):1058–1064. 10.7196/SAMJ.2017.v107i12.12358
    1. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009. October;52(2):280–9. 10.1097/QAI.0b013e3181ab6eab
    1. Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, Sawires S, et al. Missed Opportunities for HIV Testing and Late-Stage Diagnosis among HIV-Infected Patients in Uganda. Myer L, editor. PLoS ONE. 2011. July 5;6(7):e21794 10.1371/journal.pone.0021794
    1. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, et al. Loss to Care and Death Before Antiretroviral Therapy in Durban, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2009. June;51(2):135–139. 10.1097/qai.0b013e3181a44ef2
    1. Geng EH, Bwana MB, Muyindike W, Glidden DV, Bangsberg DR, Neilands TB, et al. Failure to Initiate Antiretroviral Therapy, Loss to Follow-up and Mortality Among HIV-Infected Patients During the Pre-ART Period in Uganda. J Acquir Immune Defic Syndr. 2013. June;63(2):e64–71. 10.1097/QAI.0b013e31828af5a6
    1. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012. October;26(16):2059–67. 10.1097/QAD.0b013e3283578b9b
    1. Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo ZoneEthiopia: a case-control study. AIDS Research and Therapy. 2011. February 28;8(1):8 10.1186/1742-6405-8-8

Source: PubMed

3
Předplatit